London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound
Launched by QUEEN MARY UNIVERSITY OF LONDON · Jan 25, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better detect heart valve diseases and heart failure in a diverse community using a special test called cardiac ultrasound, which is like a video that shows how the heart is working. Heart valve diseases and heart failure are serious conditions that often lead to emergency hospital visits, especially for people over 65. The goal of the study is to train healthcare workers in the community to perform these ultrasound tests, making it easier to find heart problems early and manage them before they lead to hospital admissions.
To be eligible for this trial, participants need to be 65 years old or older. People with certain conditions, like Alzheimer's disease or those receiving palliative care, will not be included. If you join the trial, you can expect to receive a cardiac ultrasound that will be reviewed by experts. The data collected will help researchers develop better tools for diagnosing heart conditions in the future, ultimately aiming to improve health outcomes and reduce the need for emergency care in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Greater or equal to 65 years old
- Exclusion Criteria:
- • Clinical diagnosis of Alzheimer's Disease or Vascular Dementia
- • Palliative Care patients.
About Queen Mary University Of London
Queen Mary University of London is a prestigious research-intensive institution recognized for its commitment to advancing medical science and improving health outcomes. As a leading sponsor of clinical trials, the university harnesses its academic excellence and innovative research capabilities to explore groundbreaking treatments and therapies across various medical disciplines. With a focus on collaboration, the institution engages with a diverse network of clinicians, researchers, and industry partners to ensure rigorous study design, ethical conduct, and the translation of research findings into clinical practice. Queen Mary University of London is dedicated to contributing to the global body of knowledge in healthcare through high-quality clinical research that prioritizes patient safety and welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials